Non-Invasive Prenatal Testing (NIPT) is an early screening tool for the detection of fetal chromosomal abnormalities by analyzing cell free fetal DNA (cffDNA) in maternal plasma. However, detecting these abnormalities can be challenging in a high background of maternal cell free DNA. To support existing research methods and the development of new workflows, high quality reference materials are needed that can accurately mimic patient samples. Join us to learn about how key technologies are advancing the production of reference materials in this critical area.
Mimix™ for research use only. Not for use in diagnostic procedures. Vanadis™ NIPT platform products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.